Boston, MA 09/26/2013 (wallstreetpr) – Wednesday’s trading
In Wednesday’s trading session, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock dropped by 1.34%. The shares opened at a price of $103.64, climbed to an intraday high of $103.74 and headed to a close of $102.34. Approximately 0.852 million shares were traded on Wednesday and an average volume of 1.14 million shares were traded over a period of 30 days. The 52-week low of the shares was $52.52 and the 52-week high was $106.98. The company has a market capitalization of $34.07 billion.
About the company
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was previously known as Biovail Corporation. It is a multinational, specialty-pharmaceutical company. It is involved in the development, manufacture and marketing of a variety of pharmaceutical products. It operates in 5 business segments: Canada and Australia, U.S. Neurology and Other, U.S. Dermatology, Branded Generics -Latin America and Branded Generics – Europe
Within the U.S. Dermatology segment and its Branded Generic – Europe segment it generates service-revenue from contract-services in the areas of topical medication and dermatology. On 12 December 2011, it acquired Janssen Pharmaceuticals’ Ortho Dermatologics division assets. On 16 December 2011, it acquired the dermatology-business, Dermik, of Sanofi.
More acquisitions
On 21 December 2011, the company acquired iNova, from Ironbridge Capital, Archer Capital, and other minority-management shareholders. On 1 February 2012, it bought Probiotica Laboratorios Ltda. On 3 February 2012, the Company Valeant Pharmaceuticals Intl Inc (NYSE:VRX) divesting 1% clindamycin and the 5% of benzoyl peroxide gel, which is a generic-version of Benzaclin. Apart from this it also divested 5% fluorouracil cream to to Mylan Inc.
The product is an authorized-generic of Efudex, On 12 March 2012, it bought a 19.9 percent minority-equity investment in Pele Nova Biotecnologia. In 2012 September, it acquired Visudyne. This is used in the treatment of abnormal growth of leaky blood-vessels in the eye that are caused by wet, age-related macular-degeneration.
